Literature DB >> 25505331

Antigen dependently activated cluster of differentiation 8-positive T cells cause perforin-mediated neurotoxicity in experimental stroke.

Eva Mracsko1, Arthur Liesz2, Ana Stojanovic3, Wilson Pak-Kin Lou4, Matthias Osswald5, Wei Zhou1, Simone Karcher1, Frank Winkler5, Ana Martin-Villalba4, Adelheid Cerwenka3, Roland Veltkamp6.   

Abstract

Neuroinflammation plays a key role in secondary brain damage after stroke. Although deleterious effects of proinflammatory cytokines are well characterized, direct cytotoxic effects of invading immune cells on the ischemic brain and the importance of their antigen-dependent activation are essentially unknown. Here we examined the effects of adaptive and innate immune cells-cytotoxic T lymphocytes (CTLs) and natural killer (NK) cells-that share the direct perforin-mediated cytotoxic pathway on outcome after cerebral ischemia in mice. Although CTLs and NK cells both invaded the ischemic brain, only brain-infiltrating CTLs but not NK cells were more activated than their splenic counterparts. Depletion of CTLs decreased infarct volumes and behavioral deficit in two ischemia models, whereas NK cell depletion had no effect. Correspondingly, adoptive CTL transfer from wild-type into Rag1 knock-out mice increased infarct size. Adoptive CTL transfer from perforin knock-out or interferon-γ knock-out mice into Rag1 knock-out mice revealed that CTL neurotoxicity was mediated by perforin. Accordingly, CTLs isolated from wild-type or interferon-γ knock-out but not from perforin knock-out mice induced neuronal cell death in vitro. CTLs derived from ovalbumin-specific T-cell receptor transgenic mice were not activated and infiltrated less into the ischemic brain compared with wild-type CTLs. Their transfer did not increase the infarct size of Rag1 knock-out mice, indicating antigen-dependent activation as an essential component of CTL neurotoxicity. Our findings underscore the importance of antigen-dependent, direct cytotoxic immune responses in stroke and suggest modulation of CTLs and their effector pathways as a potential new strategy for stroke therapy.
Copyright © 2014 the authors 0270-6474/14/3416784-12$15.00/0.

Entities:  

Keywords:  NK cells; cytotoxic T lymphocytes; ischemic stroke; perforin

Mesh:

Substances:

Year:  2014        PMID: 25505331      PMCID: PMC6608504          DOI: 10.1523/JNEUROSCI.1867-14.2014

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  45 in total

Review 1.  CD8+ T cell effector mechanisms in resistance to infection.

Authors:  J T Harty; A R Tvinnereim; D W White
Journal:  Annu Rev Immunol       Date:  2000       Impact factor: 28.527

Review 2.  Antigen-specific regulation of T cell-mediated cytokine production.

Authors:  M K Slifka; J L Whitton
Journal:  Immunity       Date:  2000-05       Impact factor: 31.745

3.  Proinflammatory cytokines and early neurological worsening in ischemic stroke.

Authors:  N Vila; J Castillo; A Dávalos; A Chamorro
Journal:  Stroke       Date:  2000-10       Impact factor: 7.914

4.  Autoimmune lymphoproliferative syndrome and perforin.

Authors:  Frédéric Rieux-Laucat; Françoise Le Deist; Geneviève De Saint Basile
Journal:  N Engl J Med       Date:  2005-01-20       Impact factor: 91.245

5.  Mechanism of natural killer (NK) cell regulatory role in experimental autoimmune encephalomyelitis.

Authors:  Wen Xu; Gyorgy Fazekas; Hideo Hara; Takeshi Tabira
Journal:  J Neuroimmunol       Date:  2005-06       Impact factor: 3.478

Review 6.  Natural killer cells in antiviral defense: function and regulation by innate cytokines.

Authors:  C A Biron; K B Nguyen; G C Pien; L P Cousens; T P Salazar-Mather
Journal:  Annu Rev Immunol       Date:  1999       Impact factor: 28.527

7.  Cytotoxic T lymphocytes are activated following myocardial infarction and can recognize and kill healthy myocytes in vitro.

Authors:  N Varda-Bloom; J Leor; D G Ohad; Y Hasin; M Amar; R Fixler; A Battler; M Eldar; D Hasin
Journal:  J Mol Cell Cardiol       Date:  2000-12       Impact factor: 5.000

8.  Chronic behavioral testing after focal ischemia in the mouse: functional recovery and the effects of gender.

Authors:  Xiaoling Li; Kathleen K Blizzard; Zhiyuan Zeng; A Courtney DeVries; Patricia D Hurn; Louise D McCullough
Journal:  Exp Neurol       Date:  2004-05       Impact factor: 5.330

9.  A test for detecting long-term sensorimotor dysfunction in the mouse after focal cerebral ischemia.

Authors:  Li Zhang; Timothy Schallert; Zheng Gang Zhang; Quan Jiang; Polly Arniego; Qingjiang Li; Mei Lu; Michael Chopp
Journal:  J Neurosci Methods       Date:  2002-06-30       Impact factor: 2.390

10.  A role for interferon-gamma in focal cerebral ischemia in mice.

Authors:  Kate Lykke Lambertsen; Rikke Gregersen; Michael Meldgaard; Bettina Hjelm Clausen; Eva Kildall Heibøl; Rune Ladeby; Jens Knudsen; Aase Frandsen; Trevor Owens; Bente Finsen
Journal:  J Neuropathol Exp Neurol       Date:  2004-09       Impact factor: 3.685

View more
  39 in total

Review 1.  Clinical Trials of Immunomodulation in Ischemic Stroke.

Authors:  Roland Veltkamp; Dipender Gill
Journal:  Neurotherapeutics       Date:  2016-10       Impact factor: 7.620

Review 2.  Peroxisome proliferator-activated receptor γ (PPARγ): A master gatekeeper in CNS injury and repair.

Authors:  Wei Cai; Tuo Yang; Huan Liu; Lijuan Han; Kai Zhang; Xiaoming Hu; Xuejing Zhang; Ke-Jie Yin; Yanqin Gao; Michael V L Bennett; Rehana K Leak; Jun Chen
Journal:  Prog Neurobiol       Date:  2017-10-12       Impact factor: 11.685

Review 3.  Immune responses in stroke: how the immune system contributes to damage and healing after stroke and how this knowledge could be translated to better cures?

Authors:  Aditya Rayasam; Martin Hsu; Julie A Kijak; Lee Kissel; Gianna Hernandez; Matyas Sandor; Zsuzsanna Fabry
Journal:  Immunology       Date:  2018-03-26       Impact factor: 7.397

Review 4.  The impact of sex and age on T cell immunity and ischemic stroke outcomes.

Authors:  Hilda Ahnstedt; Louise D McCullough
Journal:  Cell Immunol       Date:  2019-08-01       Impact factor: 4.868

5.  Astrocyte-derived interleukin-15 exacerbates ischemic brain injury via propagation of cellular immunity.

Authors:  Minshu Li; Zhiguo Li; Yang Yao; Wei-Na Jin; Kristofer Wood; Qiang Liu; Fu-Dong Shi; Junwei Hao
Journal:  Proc Natl Acad Sci U S A       Date:  2016-12-19       Impact factor: 11.205

Review 6.  Hemorrhagic Transformation After Tissue Plasminogen Activator Treatment in Acute Ischemic Stroke.

Authors:  Chengli Liu; Jie Xie; Shanshan Sun; Hui Li; Tianyu Li; Chao Jiang; Xuemei Chen; Junmin Wang; Anh Le; Jiarui Wang; Zhanfei Li; Jian Wang; Wei Wang
Journal:  Cell Mol Neurobiol       Date:  2020-10-30       Impact factor: 5.046

Review 7.  Immune Cells After Ischemic Stroke Onset: Roles, Migration, and Target Intervention.

Authors:  Lu-Yao Ao; Yun-Yi Yan; Lin Zhou; Cheng-Yuan Li; Wan-Ting Li; Wei-Rong Fang; Yun-Man Li
Journal:  J Mol Neurosci       Date:  2018-10-01       Impact factor: 3.444

Review 8.  The evolving role of neuro-immune interaction in brain repair after cerebral ischemic stroke.

Authors:  Xin Wang; Wei Xuan; Zi-Yu Zhu; Yan Li; Hao Zhu; Ling Zhu; Dan-Yun Fu; Li-Qun Yang; Pei-Ying Li; Wei-Feng Yu
Journal:  CNS Neurosci Ther       Date:  2018-10-22       Impact factor: 5.243

Review 9.  Long-term T cell responses in the brain after an ischemic stroke.

Authors:  Uma Maheswari Selvaraj; Ann M Stowe
Journal:  Discov Med       Date:  2017-12       Impact factor: 2.970

Review 10.  Inflammatory Disequilibrium in Stroke.

Authors:  Danica Petrovic-Djergovic; Sascha N Goonewardena; David J Pinsky
Journal:  Circ Res       Date:  2016-06-24       Impact factor: 17.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.